The Centers for Disease Control and Prevention (CDC) provide this interactive mapping of dengue across the world and can be used for risk assessment.
Saved once (save)Bookmarked by The Editorial Team on Dec. 4, 2011
A Nicaraguan study is helping scientists understand why a second dengue fever infection can be more severe than the first one.
This article is in Spanish but can be translated easily through the google translate toolbar which can be easily and quickly downloaded for free here: http://www.google.com/toolbar/ie/index.html
Saved once (save)Bookmarked by The Editorial Team on Jan. 17, 2012
Dengue fever outbreaks are increasing in both frequency and magnitude. Not only that, the number of countries that could potentially be ...
BluSense diagnostics has launched a dengue survey to learn more about the diagnostics requirements of the dengue community. If you ...
Dengue fever is a global concern - we urge the United Nations to designate a World Dengue Day at its General Assembly in September 2019
Treatment with antibiotics depletes the gut microbiota in mice, making them more susceptible to infection by dengue, zika and west nile virus.
Researchers have demonstrated that the recent ZIKV outbreak in Latin America substantially affects the DENV serology in routine diagnostic laboratories.
Results from this study indicate that bats do not sustain sufficient virus amplification in order to function as reservoirs and exclude them as players in the dengue virus transmission cycle.
Dengue is a mosquito-borne disease that threatens over half of the world’s population. Despite being endemic to more than 100 countries, government-led efforts and tools for timely identification and tracking of new infections are still lacking in many affected areas. Multiple methodologies that leverage the use of Internet-based data sources have been proposed as a way to complement dengue surveillance efforts. Among these, dengue-related Google search trends have been shown to correlate with dengue activity. We extend a methodological framework, initially proposed and validated for flu surveillance, to produce near real-time estimates of dengue cases in five countries/states: Mexico, Brazil, Thailand, Singapore and Taiwan. Our result shows that our modeling framework can be used to improve the tracking of dengue activity in multiple locations around the world.
World Health Organization (WHO) recommendations on the use of dengue vaccine
São João del Rei has recorded another death from dengue fever - the second in 2016 so far.
Review of articles on communication strategies for vector-borne diseases
Strengthening integrated dengue surveillance, monitoring and response systems
Evaluation of NS1 antigen assay as an alternative to RT-PCR for the early diagnosis of dengue
Evaluation of rapid diagnostic test for dengue virus
Analysis of potential dengue vaccine impact in Yucatán Mexico.
An estimate of the global economic burden of dengue by country and super-region
This paper looks at the true cost of dengue fever
Secondary analysis of clinical trial data reveals dengue burden
Vector control, surveillance, drugs, diagnostics and vaccines all hold exciting potential but none can solve the problem alone. We need an integrated approach.
Research points to a promising single antiviral for the transgenic suppression of multiple arboviruses
Scientists belive a protein may be key to new dengue drug discoveries?
With Zika infection rates now seeming to be on the increase, the Oxford Science Blog talked to Professor Lang about why it is so important to develop capacity for doing research in places where research doesn't normally happen.
Abstract The increasing population of Aedes aegypti mosquitoes on Madeira Island (Portugal) resulted in the first autochthonous dengue outbreak, which occurred in October 2012. Our study establishes the first genetic evaluation based on the mitochondrial DNA (mtDNA) genes [cytochrome oxidase subunit I (COI) and NADH dehydrogenase subunit 4 (ND4)] and knockdown resistance ( kdr ) mutations exploring the colonisation history and the genetic diversity of this insular vector population. We included mosquito populations from Brazil and Venezuela in the analysis as putative geographic sources. The Ae. aegypti population from Madeira showed extremely low mtDNA genetic variability, with a single haplotype for COI and ND4. We also detected the presence of two important kdr mutations and the quasi-fixation of one of these mutations (F1534C). These results are consistent with a unique recent founder event that occurred on the island of Ae. aegypti mosquitoes that carry kdr mutations associated with insecticide resistance. Finally, we also report the presence of the F1534C kdr mutation in the Brazil and Venezuela populations. To our knowledge, this is the first time this mutation has been found in South American Ae. aegypti mosquitoes. Given the present risk of Ae. aegypti re-invading continental Europe from Madeira and the recent dengue outbreaks on the island, this information is important to plan surveillance and control measures.
Abstract Objective: To describe the mortality of dengue in Mexico during 1980 to 2009. Method: Dengue mortality data for Mexico were obtained from Instituto Nacional de Estadistica, Geografía e Informática. We used standardized and non-standardized dengue mortality rates per 1,000,000 people and determined the mortality trend. The groups were based on International Classification of Diseases coding criteria (ICD-9 E061 and ICD-10 A91X). The results were stratified by age groups and the frequencies of dengue deaths were compared using relative risk (RR) with its 95% confidence interval. Results: During 1980 to 2009 in Mexico, 549 deaths due to dengue were reported. We found an important variation in the mortality rates during the years studied. We were able to identify three periods: 1980 to 1992, 1994 to 2000, and 2001 to 2009. The mortality rates found are from 0.88/1,000,000 through 0.00/1,000,000. The average mortality rates by decade: 1980 to 1989: 0.53/1,000,000; 1990 to 1999: 0.06/1,000,000; 2000 to 2009: 0.12/1,000,000. In the analysis of mortality by community size during 2000 to 2009, we observed in the small communities with less than 2499 people, the risk is 1.25 times higher than in those with more than 20,000 people. Conclusions: We found, in general, a sustained decline in the number of deaths by dengue over the last 30 years in Mexico. However, a slow increase was observed since 1994, which may be related to the circulation of DENV2 and DENV3, among other factors. We need to strengthen prevention programs in smaller communities (<2499) where we found a higher risk of mortality due to dengue.
Here is a selection of content from the network which matches the selected tag.